Connect with us


Third member of US FDA advisory panel resigns over Alzheimer’s drug approval – Fox Business



Article feature image

A third member of a panel of outside advisers to the U.S. Food and Drug Administration has resigned in protest over the agency’s decision to approve Biogen Inc’s Alzheimer’s disease treatment despite the committee’s recommendation against doing so.

Click here to view the original article.

Continue Reading

You might also like ...

Article feature image
Mortgage rates shoot higher after Fed Chairman Powell’s comments – NBC News
Article feature image
Cruise operator Carnival discloses breach of crew, guests’ personal data – Bloomberg News – Reuters
Article feature image
FAA defends SpaceX in front of Congress despite unauthorized Starship launch – CNBC